 | Protagonist Therapeutics, Inc. | |||
| NGM : PTGX || Location: United States | ||||
$27.24+0.63 (+2.37%) |
0.15 M | 26.61 - 27.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.439 M |
| March 15, 2024 | 3.418 M |
| Feb. 29, 2024 | 2.936 M |
| Feb. 15, 2024 | 2.780 M |
| Jan. 31, 2024 | 2.610 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.03 | 0.44 | 1397.94% |
| 09/30/2023 | -0.71 | -0.58 | 18.04% |
| 06/30/2023 | -0.66 | -0.68 | -2.98% |
| 03/31/2023 | -0.74 | -0.67 | 9.61% |
| 12/31/2022 | -0.65 | -0.69 | -5.97% |
PTGX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 58.275M | Shares Float | 40.661M |
| Short Float | 3.439M | Market Cap | 1550.70M |
| Institution ownership | 0.00% | Insider ownership | 1.707% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.39 | Forward EPS | -0.81 |